P21 Dosage Guide
20/100 confidenceComplete guide to P21 dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
5 mg
Route
multiple
Frequency
1x daily
Cycle Length
2-4 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Research protocols typically use 1-5mg administered intranasally or subcutaneously. Often used in cycles of 2-4 weeks.
Administration Method
Can be administered intranasally for direct CNS access or subcutaneously. Best used cyclically rather than continuously.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Quick Calculator
Concentration: 2,500 mcg/ml
Volume to inject: 2.00 ml
Syringe units (U-100): 200.0 units
Pre-filled with P21 defaults. Adjust values as needed.
Research Backing
Preclinical rodent Alzheimer’s models \+ limited human observational nootropic protocols; patent and early mechanistic studies.
Side Effects to Monitor
Limited data. Reported effects include mild headache, temporary brain fog during initial use, and fatigue.
Safety Considerations & Risks
Very limited human research. Long-term effects unknown. Theoretical concerns about effects on cell proliferation pathways.